Literature DB >> 23127619

The DOPPS Practice Monitor for US dialysis care: trends through December 2011.

Douglas S Fuller1, Ronald L Pisoni, Brian A Bieber, Brenda W Gillespie, Bruce M Robinson.   

Abstract

Mesh：

Year:  2012        PMID： 23127619     DOI： 10.1053/j.ajkd.2012.10.002

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  25 in total

1.  Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Authors:  Julia B Lewis; Mohammed Sika; Mark J Koury; Peale Chuang; Gerald Schulman; Mark T Smith; Frederick C Whittier; Douglas R Linfert; Claude M Galphin; Balaji P Athreya; A Kaldun Kaldun Nossuli; Ingrid J Chang; Samuel S Blumenthal; John Manley; Steven Zeig; Kotagal S Kant; Juan Jose Olivero; Tom Greene; Jamie P Dwyer
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

2.  Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.

Authors:  Navdeep Tangri; Dana C Miskulin; Jing Zhou; Karen Bandeen-Roche; Wieneke M Michels; Patti L Ephraim; Aidan McDermott; Deidra C Crews; Julia J Scialla; Stephen M Sozio; Tariq Shafi; Bernard G Jaar; Klemens Meyer; L Ebony Boulware
Journal:  Nephrol Dial Transplant       Date:  2014-11-02       Impact factor: 5.992

3.  Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

Authors:  Kausik Umanath; Diana I Jalal; Barbara A Greco; Ebele M Umeukeje; Efrain Reisin; John Manley; Steven Zeig; Dana G Negoi; Anand N Hiremath; Samuel S Blumenthal; Mohammed Sika; Robert Niecestro; Mark J Koury; Khe-Ni Ma; Tom Greene; Julia B Lewis; Jamie P Dwyer
Journal:  J Am Soc Nephrol       Date:  2015-03-03       Impact factor: 10.121

Review 4.  Evaluation of fracture risk in chronic kidney disease.

Authors:  Pablo Antonio Ureña Torres; Martine Cohen-Solal
Journal:  J Nephrol       Date:  2017-04-06       Impact factor: 3.902

Review 5.  Iron and infection in hemodialysis patients.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  Semin Dial       Date:  2013-12-12       Impact factor: 3.455

6.  Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.

Authors:  Angelo Karaboyas; Jarcy Zee; Hal Morgenstern; Jacqueline G Nolen; Raymond Hakim; Kamyar Kalantar-Zadeh; Philip Zager; Ronald L Pisoni; Friedrich K Port; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

7.  Intravenous iron exposure and mortality in patients on hemodialysis.

Authors:  Dana C Miskulin; Navdeep Tangri; Karen Bandeen-Roche; Jing Zhou; Aidan McDermott; Klemens B Meyer; Patti L Ephraim; Wieneke M Michels; Bernard G Jaar; Deidra C Crews; Julia J Scialla; Stephen M Sozio; Tariq Shafi; Albert W Wu; Courtney Cook; L Ebony Boulware
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

8.  Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?

Authors:  Marc N Turenne; Elizabeth L Cope; Shannon Porenta; Purna Mukhopadhyay; Douglas S Fuller; Jeffrey M Pearson; Claudia Dahlerus; Brett Lantz; Francesca Tentori; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2014-10-09       Impact factor: 10.121

9.  International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.

Authors:  Douglas S Fuller; Brian A Bieber; Ronald L Pisoni; Yun Li; Hal Morgenstern; Tadao Akizawa; Stefan H Jacobson; Francesco Locatelli; Friedrich K Port; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2015-11-18       Impact factor: 10.121

10.  Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study).

Authors:  Loreto Gesualdo; Christian Combe; Adrian Covic; Frank Dellanna; David Goldsmith; Gérard London; Johannes F Mann; Philippe Zaoui; Matthew Turner; Mike Muenzberg; Karen MacDonald; Ivo Abraham
Journal:  Int Urol Nephrol       Date:  2015-04-17       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.